Related references
Note: Only part of the references are listed.Biallelic Mutations in SLC1A2; an Additional Mode of Inheritance for SLC1A2-Related Epilepsy
Matias Wagner et al.
NEUROPEDIATRICS (2018)
De Novo Mutations in YWHAG Cause Early-Onset Epilepsy
Ilaria Guella et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies
Candace T. Myers et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
The Hydroxyl Side Chain of a Highly Conserved Serine Residue Is Required for Cation Selectivity and Substrate Transport in the Glial Glutamate Transporter GLT-1/SLC1A2
Alexandre Simonin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Conditional Deletion of the Glutamate Transporter GLT-1 Reveals That Astrocytic GLT-1 Protects against Fatal Epilepsy While Neuronal GLT-1 Contributes Significantly to Glutamate Uptake into Synaptosomes
Geraldine T. Petr et al.
JOURNAL OF NEUROSCIENCE (2015)
cAMP Response Element-binding Protein (CREB) and Nuclear Factor κB Mediate the Tamoxifen-induced Up-regulation of Glutamate Transporter 1 (GLT-1) in Rat Astrocytes
Pratap Karki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
De novo mutations in epileptic encephalopathies
Andrew S. Allen et al.
NATURE (2013)
Riluzole elevates GLT-1 activity and levels in striatal astrocytes
Marica Carbone et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Fluoxetine treatment induces EAAT2 expression in rat brain
M. Zink et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism
S. Xu et al.
CYTOGENETIC AND GENOME RESEARCH (2008)
Differential promotion of glutamate transporter expression and function by glucocorticoids in astrocytes from various brain regions
J Zschocke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
JD Rothstein et al.
NATURE (2005)
Share Paper
